This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Seres Therapeutics Inc
Apogee Therapeutics, Inc.
XCF Global, Inc. Class A
SpaceX
Faeth Therapeutics, Inc.
Seres Therapeutics Inc MCRB | 0.00 | |
Apogee Therapeutics, Inc. APGE | 0.00 | |
XCF Global, Inc. Class A SAFX | 0.00 | |
SpaceX SPCX | 0.00 | |
Faeth Therapeutics, Inc. FTH | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Matthew Keller initiated coverage on Seres Therapeutics Inc (NASDAQ:MCRB) with a Buy rating and announced a price target of $12. Seres Therapeutics shares closed at $6.60 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Amit Dayal initiated coverage on XCF Global Inc (NASDAQ:SAFX) with a Buy rating and announced a price target of $1. XCF Global shares closed at $0.49 on Monday. See how other analysts view this stock.
- Deutsche Bank analyst Kieran Ryan initiated coverage on DexCom Inc (NASDAQ:DXCM) with a Buy rating and announced a price target of $86. DexCom shares closed at $69.07 on Monday. See how other analysts view this stock.
- Deutsche Bank analyst Kieran Ryan initiated coverage on Insulet Corporation (NASDAQ:PODD) with a Buy rating and announced a price target of $190. Insulet shares closed at $138.97 on Monday. See how other analysts view this stock.
- Deutsche Bank analyst Kieran Ryan initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a Hold rating and announced a price target of $15.5. Tandem Diabetes Care shares closed at $14.34 on Monday. See how other analysts view this stock.
Considering buying MCRB stock? Here’s what analysts think:
Photo via Shutterstock